Clinical, genetic and quality-of-life study of a cohort of adult patients with tuberous sclerosis.
No Thumbnail Available
Identifiers
Date
2021-05-31
Authors
De Sautu De Borbón, Elena Cristina
Guerra Vales, Juan Manuel
Lumbreras Bermejo, Carlos
Guerrero Ramos, Felix
Buj Padilla, María José
González de la Aleja, Jesús
Morales Conejo, Montserrat
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Tuberous sclerosis (TS) is a condition whose manifestations in childhood have been extensively described, but whose presentation in adults is less well known. This study describes the clinical and genetic characteristics, therapeutic management and quality of life of a cohort of adult patients with TS. A comparative study of the characteristics of patients diagnosed in childhood and adulthood is also carried out. This observational, retrospective, cross-sectional study included a large cohort of adult patients (≥ 16 years old) followed for 5 years in a specific rare diseases unit. Fifty-seven patients with a diagnosis of tuberous sclerosis were included, more than 50% of whom were diagnosed as adults. The mean age of the patients was 42 years (20-86). The central nervous system was the main area affected (97%), followed by the skin (80.7%) and kidneys (73%). The most frequent genetic alteration was a mutation in the TSC2 gene (47.7%). Among patients diagnosed in adulthood, there was less neurological involvement, with less frequency of epileptic seizures (30.8% vs 60.79% of patients diagnosed in childhood) and astrocytomas (3.8% vs 53.6%), less intellectual disability (11.5% vs 71.4%) and less expressiveness of the condition. 42% of patients were treated with mTOR pathway inhibitors, and presence of an angiomyolipoma was the main indication. In a quality-of-life analysis, the means of the summary indices were below the scores of the average Spanish population: (47.42 (SD ± 9.82) on the physical health scale, 45.61 (SD ± 7.99) on the mental health scale) versus 50 (SD ± 10) for the general population. Up to 50% of adult patients with TS were diagnosed in adulthood, and the condition is less severe with less frequent epileptic seizures and intellectual disability. 42% require treatment with mTOR inhibitors, in most cases due to the presence of AMLs. The quality of life of adult patients with TS is diminished compared to the general population.
Description
MeSH Terms
Adolescent
Adult
Aged
Aged, 80 and over
Angiomyolipoma
Cross-Sectional Studies
Humans
Middle Aged
Quality of Life
Retrospective Studies
Tuberous Sclerosis
Young Adult
Adult
Aged
Aged, 80 and over
Angiomyolipoma
Cross-Sectional Studies
Humans
Middle Aged
Quality of Life
Retrospective Studies
Tuberous Sclerosis
Young Adult
DeCS Terms
CIE Terms
Keywords
Adult, Multidisciplinary unit, Quality of life, Tuberous sclerosis